menu
    • menu

    Company profile for The Biovac Institute

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biovac started its journey with a big bold step that covered a lot of ground in short space of time. While developing our manufacturing facilities, we have been importing, exporting, packaging, testing and distributing vaccines. Our leap of faith ensured that we delivered the required vaccines to the children’s vaccination program, known as the Expanded Programme on Immunisation, in South Africa and the region. To ensure ...
    Biovac started its journey with a big bold step that covered a lot of ground in short space of time. While developing our manufacturing facilities, we have been importing, exporting, packaging, testing and distributing vaccines. Our leap of faith ensured that we delivered the required vaccines to the children’s vaccination program, known as the Expanded Programme on Immunisation, in South Africa and the region. To ensure continued and seamless delivery; we coordinate supply and demand with offshore suppliers, the South African Department of Health and other partners to ensure that the required vaccines

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Biovac InstituteSouthAfrica Flag
    Country
    Country
    South Africa
    Address
    Address
    off Raapenberg Road, Golf Park 4 Unit 2A, Ground Floor Mowbray 7700 Cape Town
    Telephone
    Telephone
    +27 21 514 5000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biovac.co.za/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biovac Gets $108M Backing For Vaccine Factory In South Africa
    Biovac Gets $108M Backing For Vaccine Factory In South Africa

    17 Apr 2026

    // ENDPOINTS

    https://endpoints.news/biovac-gets-108m-backing-for-vaccine-factory-in-south-africa/

    ENDPOINTS
    17 Apr 2026
    Share Share
    Biovac deals with Sanofi, EuBiologics to bolster African polio vaccines
    Biovac deals with Sanofi, EuBiologics to bolster African polio vaccines

    21 Jun 2024

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/south-africas-biovac-inks-double-deals-sanofi-eubiologics-bolster-african-supply

    Zoey Becker FIERCE PHARMA
    21 Jun 2024
    Share Share
    Sanofi And Biovac Spearhead Polio Vaccine Manufacturing Capabilities In Africa
    Sanofi And Biovac Spearhead Polio Vaccine Manufacturing Capabilities In Africa

    20 Jun 2024

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2024/2024-06-20-12-00-00-2901636

    PRESS RELEASE
    20 Jun 2024
    Share Share
    Biovac and IVI enter deal to develop oral cholera vaccine
    Biovac and IVI enter deal to develop oral cholera vaccine

    24 Nov 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/biovac-oral-cholera-vaccine/

    PHARMACEUTICAL-TECHNOLOGY
    24 Nov 2022
    Share Share
    South Africa's Biovac in new oral cholera vaccine deal
    South Africa's Biovac in new oral cholera vaccine deal

    23 Nov 2022

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/south-africas-biovac-new-oral-cholera-vaccine-deal-2022-11-23/

    REUTERS
    23 Nov 2022
    Share Share
    Biovac partnership to increase African vaccine manufacturing capabilities
    Biovac partnership to increase African vaccine manufacturing capabilities

    23 Nov 2022

    // CPHI-ONLINE

    https://www.cphi-online.com/biovac-partnership-to-increase-african-vaccine-news119464.html

    CPHI-ONLINE
    23 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search